GENETIC ANALYSIS OF STRESS RESISITANCE /LOSS OF HEARING

抗应激/听力损失的遗传分析

基本信息

  • 批准号:
    6966784
  • 负责人:
  • 金额:
    $ 27.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-01 至 2010-07-31
  • 项目状态:
    已结题

项目摘要

This project focuses on analysis of the genetic controls and physiological regulators that modulate hearing loss in a population of genetically heterogeneous mice. The test population will consist of 600 animals bred as the progeny of (CAST/Ei X 129S1/SvImJ)F1 females and (C3H/HeJ X FVB/NJ)F1 males. Each mouse generated in this four-way cross is genetically unique, and a full sib to each other animal in the population. Each mouse will be tested for hearing acuity by auditory brainstem response at ages 2, 8, 14, 18 and 22 months. Half of the 600 mice will be exposed to noise-induced cochlear injury at age 14.5 months. SNP-based genotyping at each of 300 loci will provide a genomic map of loci modulating hearing acuity, its change over age, and its resistance to noise-induced damage (Aim 1). Aim 2 will test the hypothesis that hearing loss is related to, and predictable by, individual differences in cellular resistance to oxidative cytotoxic stress, using in vitro analyses of fibroblast cell lines from each tested mouse. This strategy reflects recent evidence that mutations that retard aging and extend life span in mice may do so by alterations of stress-sensitivity in multiple cell types, including fibroblasts. Aim 3 will test the hypothesis that the genes, and potentially the non-genetic factors, that modulate functional hearing loss and cellular stress resistance also affect cochlear hair cell loss and oxidative damage to cochlear structures. Aim 4 tests a series of related hypothesis concerning the effects of early-life growth, maturation, and hormone patterns on mid- and late-life stress resistance and functional outcome, including hearing loss. Aim 5 will measure a range of age-sensitive traits, including indices of immunity and visual function, to test the hypothesis that inter-individual differences in age-related hearing loss are linked to differences among mice in multiple aspects of aging. This strategy will also yield, as a useful byproduct, a great deal of genetic information about loci that modulate growth, maturation, stress resistance, cataracts, hormones, and immunity in young and older mice. The approach chosen will permit a comprehensive assessment of the extent to which age-depending alterations in hearing are molded by genetic, cellular and hormonal factors that time the aging process in mice.
该项目的重点是分析调节遗传异质性小鼠群体听力损失的遗传控制和生理调节因子。试验群体将由600只作为(CAST/Ei X 129 S1/SvImJ)F1雌性和(C3 H/HeJ X FVB/NJ)F1雄性后代繁殖的动物组成。在这种四向杂交中产生的每只小鼠在遗传上都是独特的,并且是种群中每只动物的全同胞。在2、8、14、18和22月龄时,通过听觉脑干反应测试每只小鼠的听力敏锐度。600只小鼠中的一半将在14.5个月大时暴露于噪声诱导的耳蜗损伤。基于snp 在300个基因座中的每一个上进行基因分型将提供调节听力敏锐度的基因座的基因组图谱,其 随着年龄的变化,以及其对噪音引起的损害的抵抗力(目标1)。目的2将使用来自每只受试小鼠的成纤维细胞系的体外分析,检验听力损失与细胞对氧化细胞毒性应激的耐受性的个体差异相关并可通过其预测的假设。这一策略反映了最近的证据,即延缓衰老和延长小鼠寿命的突变可能是通过改变多种细胞类型(包括成纤维细胞)的应激敏感性来实现的。目的3将检验这样的假设,即调节功能性听力损失和细胞应激抵抗力的基因和潜在的非遗传因素也影响耳蜗毛细胞损失和耳蜗结构的氧化损伤。目的4测试一系列有关早期生命生长、成熟和激素模式对中年和晚年应激抵抗力和功能结果(包括听力损失)的影响的相关假设。目标5将测量一系列年龄敏感性特征,包括免疫力和视觉功能指数,以检验年龄相关性听力损失的个体间差异与小鼠衰老多个方面的差异有关的假设。这种策略还将产生一个有用的副产品,即关于调节年轻和老年小鼠生长、成熟、抗应激、白内障、激素和免疫力的基因座的大量遗传信息。所选择的方法将允许全面评估听力中年龄依赖性变化的程度,这些变化是由遗传,细胞和激素因素塑造的,这些因素决定了小鼠的衰老过程。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD A MILLER其他文献

METFORMIN-INDUCED LACTIC ACIDOSIS COMPLICATED BY ACUTE LIVER FAILURE
  • DOI:
    10.1016/j.chest.2023.07.1294
  • 发表时间:
    2023-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    AMY PAIGE;NOREEN MIRZA;MOHAMMAD RAYAD;RICHARD A MILLER
  • 通讯作者:
    RICHARD A MILLER
PLEURAL EFFUSION-ASSOCIATED DISEASE BURDEN AND COMPLICATIONS IN A PATIENT WITH MALIGNANT MESOTHELIOMA: ANALYSIS FROM NATIONAL INPATIENT SAMPLE
  • DOI:
    10.1016/j.chest.2024.06.2264
  • 发表时间:
    2024-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    RABIA IQBAL;RUHMA ALI;WAJEEHA AIMAN;RICHARD A MILLER;NIRAV MISTRY
  • 通讯作者:
    NIRAV MISTRY
A CASE REPORT OF SEVERE PULMONARY HYPERTENSION DUE TO IDIOPATHIC PULMONARY FIBROSIS
  • DOI:
    10.1016/j.chest.2023.07.3944
  • 发表时间:
    2023-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    PRISCILLA CHOW;BARIS VEFALI;WAJEEHA AIMAN;HARI OM SHARMA;SHARATH S BELLARY;ADDI SULEIMAN;RICHARD A MILLER;AMY PAIGE
  • 通讯作者:
    AMY PAIGE
A CASE REPORT OF SEVERE TYPE A AORTIC DISSECTION IN A PATIENT WITH RHEUMATOID ARTHRITIS
  • DOI:
    10.1016/j.chest.2023.07.1955
  • 发表时间:
    2023-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    PRISCILLA CHOW;BARIS VEFALI;MOHAMMAD ABUSHANAB;RICHARD A MILLER;MARCIN KOCIUBA;AMY PAIGE
  • 通讯作者:
    AMY PAIGE
MALIGNANT GRANULAR CELL TUMOR (GCT) OF ESOPHAGUS EXTENDED INTO BRONCHUS
  • DOI:
    10.1016/j.chest.2023.07.2839
  • 发表时间:
    2023-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    KRUNAL TRIVEDI;SAHITHI CHITTAMURI;GUNWANT GURON;TAPAN THAKER;RICHARD A MILLER;YATINDER BAINS
  • 通讯作者:
    YATINDER BAINS

RICHARD A MILLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD A MILLER', 18)}}的其他基金

Integrative Omics to enhance therapeutics development for healthy aging
综合组学促进健康老龄化疗法的开发
  • 批准号:
    10693877
  • 财政年份:
    2019
  • 资助金额:
    $ 27.49万
  • 项目类别:
Integrative Omics to enhance therapeutics development for healthy aging
综合组学促进健康老龄化疗法的开发
  • 批准号:
    10475902
  • 财政年份:
    2019
  • 资助金额:
    $ 27.49万
  • 项目类别:
Integrative Omics to enhance therapeutics development for healthy aging
综合组学促进健康老龄化疗法的开发
  • 批准号:
    10452793
  • 财政年份:
    2019
  • 资助金额:
    $ 27.49万
  • 项目类别:
Integrative Omics to enhance therapeutics development for healthy aging
综合组学促进健康老龄化疗法的开发
  • 批准号:
    10017120
  • 财政年份:
    2019
  • 资助金额:
    $ 27.49万
  • 项目类别:
Laboratory for Anti-Geric Testing, Evaluation and Research
抗感冒测试、评估与研究实验室
  • 批准号:
    9899403
  • 财政年份:
    2019
  • 资助金额:
    $ 27.49万
  • 项目类别:
Comparative Biogerontology Core
比较生物老年学核心
  • 批准号:
    8122848
  • 财政年份:
    2010
  • 资助金额:
    $ 27.49万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    8122825
  • 财政年份:
    2010
  • 资助金额:
    $ 27.49万
  • 项目类别:
CORE FACILITY FOR AGED RODENTS
老年啮齿动物核心设施
  • 批准号:
    7802706
  • 财政年份:
    2009
  • 资助金额:
    $ 27.49万
  • 项目类别:
Cellular and Molecular Biology of Aging
衰老的细胞和分子生物学
  • 批准号:
    7913489
  • 财政年份:
    2009
  • 资助金额:
    $ 27.49万
  • 项目类别:
Long-lived mice and species as test beds for drug and pathway discovery
长寿小鼠和物种作为药物和途径发现的试验台
  • 批准号:
    10210339
  • 财政年份:
    2004
  • 资助金额:
    $ 27.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了